Eosinophilic esophagitis (EoE) is a chronic esophageal inflammatory disease of undetermined pathophysiology that results in dense mucosal eosinophilia and esophageal dysfunction. In childhood ...

First described nearly 20 years ago, eosinophilic esophagitis (EoE) is an inflammatory disease of the esophagus characterized by eosinophilic infiltration of the esophageal epithelium. Over 50% of ...

NS-229 is an investigational selective Janus kinase 1 inhibitor designed to prevent tissue damage caused by EGPA by suppressing immune cell activation.

In a US study, patients with severe eosinophilic esophagitis (EoE) by Index of Severity for EoE had poor responses to topical corticosteroid therapy.

Feb. 3, 2025 — A multi-institutional study has identified one of the allergens responsible for eosinophilic esophagitis (EoE), an inflammatory disease of the esophagus. This is the first time ...

Nucala has been approved to treat severe eosinophilic asthma for almost a decade, and in the interim has had its label extended to include chronic rhinosinusitis with nasal polyps, eosinophilic ...

“Despite this vulnerability to tau pathology, the association between Aβ and hippocampal atrophy was reduced in women, which could reflect some cause of brain resilience or the fact that Aβ is ...